Raoof, Sana
Mulford, Iain J.
Frisco-Cabanos, Heidie
Nangia, Varuna
Timonina, Daria
Labrot, Emma
Hafeez, Nafeeza
Bilton, Samantha J.
Drier, Yotam http://orcid.org/0000-0003-1725-2995
Ji, Fei
Greenberg, Max
Williams, August
Kattermann, Krystina
Damon, Leah http://orcid.org/0000-0002-0863-0328
Sovath, Sosathya
Rakiec, Daniel P.
Korn, Joshua M.
Ruddy, David A.
Benes, Cyril H.
Hammerman, Peter S.
Piotrowska, Zofia
Sequist, Lecia V.
Niederst, Matthew J.
Barretina, Jordi
Engelman, Jeffrey A.
Hata, Aaron N.
Funding for this research was provided by:
Ludwig Cancer Research, LungStrong
U.S. Department of Health & Human Services | National Institutes of Health (F30CA213726)
National Science Foundation (1545896)
Article History
Received: 24 July 2018
Revised: 20 March 2019
Accepted: 4 May 2019
First Online: 19 July 2019
Compliance with ethical standards
:
: IJM, EL, NH, JMK, RT, DAR, PSH, MJN, JB, and JAE are employees of Novartis Inc., as noted in the affiliations. MJN and JAE hold equity interest in Novartis Inc. ANH receives research support from Novartis, Amgen, Pfizer, and Relay Therapeutics. ZP is a consultant/advisory board member for Takeda, AstraZeneca, GuardantHealth and Novartis, and receives institutional research support from Novartis. LVS is a consultant for AstraZeneca, Boehringer-Ingelheim, Novartis, Pfizer, Genentech, Merrimack, and BMS. The other authors declare that they have no conflict of interest.